*Some Market data delayed by 15 mins.

Adverum Biotechnologies, Inc. Common Stock

Symbol: ADVM (NASDAQ)
5.38 ▲ (2.09%) 0.110

Company Description:
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Key Stats
  • Today's Open: $5.4
  • Today's High: $5.545
  • Today's Low: $5.166
  • Today's Volume: 321.70K
  • Yesterday Close: $5.27
  • Yesterday High: $5.75
  • Yesterday Low: $5
  • Yesterday Volume: 736.23K
  • Last Min Volume: 1
  • Last Min High: $5.38
  • Last Min Low: $5.38
  • Last Min VWAP: $5.38
Company Profile
  • Name: Adverum Biotechnologies, Inc. Common Stock
  • Website: https://www.adverum.com
  • Listed Date: 2014-07-31
  • Location: REDWOOD CITY, CA
  • Market Status: Active
  • CIK Number: 0001501756
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $110.59M
  • Round Lot: 100
  • Outstanding Shares: 20.98M
  • Asset Type: CS
RECENT FILINGS FOR ADVM
Filing Date Filing Type Format
2025-09-22 8-K View
2025-08-14 SCHEDULE 13G/A View
2025-08-12 10-Q View
2025-08-12 8-K View
2025-08-05 SCHEDULE 13G/A View
2025-07-16 SCHEDULE 13G/A View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
2025-06-20 4 View
Latest News on ADVM

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.